Investigating dual inhibition of ACC and CD36 for the treatment of nonalcoholic fatty liver disease in mice. Devereux CJ, Bayliss JB, Keenan SN, Montgomery MK, & Watt MJ. American Journal of Physiology – Endocrinology and Metabolism. 2/8/2023.